Trial Contacts
Primary Investigator: Bryson Katona, MD, PhD
Research Coordinator: Jordan Heiman
Email: Jordan.Heiman@pennmedicine.upenn.edu
Telephone: (215) 360-0905
Studies
Screening for Pancreatic Cancer in patients with BRCA1/2 Mutations
The study is a prospective, observational, case-control study evaluating the utility of endoscopic ultrasound for the identification of preneoplastic and neoplastic pancreatic lesions in patients at high risk for pancreatic cancer, specifically those with BRCA1/2 mutations.